FARMATEN Industrial & Commercial S.A. - Libytec Pharmaceuticals Ltd.: Sporilen

Libytec Pharmaceuticals Ltd. is pleased to announce the commencement of their collaboration with FARMATEN Industrial & Commercial S.A., regarding scientific briefing and promotion of the pharmaceutical product trade-named Sporilen.

Sporilen (cyclosporine) is a result of extensive research by EMS, Brazil’s largest pharmaceutical company, and the only company to develop a generic cyclosporine product with international circulation. Sporilen is indicated for the treatment of severe, active rheumatoid arthritis, as well as for the treatment of severe psoriasis in patients for whom conventional treatment is neither appropriate nor effective, and is available in soft capsules of 50mg and 100mg of cyclosporine, in 60-capsule packs.

FARMATEN Industrial & Commercial S.A. is one of the largest developing Greek companies, with notable international presence in the field.

Libytec is a fast-growing Greek pharmaceutical company focused on disorders of the skin and of the musculoskeletal system. The aforementioned partnership, established in March 2015 in order to promote Sporilen on the Greek market, offers the opportunity to strengthen the portfolio of its products, especially those targeting pathological conditions of the skin and musculoskeletal system, and is the inception of a series of new partnerships soon to be announced.

24, Vouliagmeni Avenue, Elliniko,
Attica 16777, Greece

  • Email:
  • Phone: +30 210 9609960
  • Fax: +30 210 9638438



We use the "Cookies" technology to facilitate the use of this website.